HMN-214 25 mg | Purity Not Available
TargetMol

HMN-214 (IVX-214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
More Information Supplier PageHMN-214 (IVX-214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
More Information Supplier PageHMN-214 (IVX-214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
More Information Supplier PageLY303511, an inactive analogue of LY294002, is a mTOR inhibitor and no inhibition for PI3-K.
More Information Supplier PageKU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2.
More Information Supplier PageAlosetron hydrochloride (GR 68755) is the hydrochloride salt form of alosetron, a potent and selective 5-HT3 receptor antagonist. Alosetron blocks the actions of serotonin at 5-HT3 sites in the peripheral nervous system, particularly on enteric and nociceptive sensory neurons, thereby affecting the regulation of visceral pain, decreasing gastrointestinal contraction and motility, and decreasing gastrointestinal secretions.
More Information Supplier PageAlosetron hydrochloride (GR 68755) is the hydrochloride salt form of alosetron, a potent and selective 5-HT3 receptor antagonist. Alosetron blocks the actions of serotonin at 5-HT3 sites in the peripheral nervous system, particularly on enteric and nociceptive sensory neurons, thereby affecting the regulation of visceral pain, decreasing gastrointestinal contraction and motility, and decreasing gastrointestinal secretions.
More Information Supplier PageDexmedetomidine is a Central alpha-2 Adrenergic Agonist. The mechanism of action of dexmedetomidine is as an Adrenergic alpha2-Agonist. The physiologic effect of dexmedetomidine is by means of General Anesthesia.
More Information Supplier Page